BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10958873)

  • 21. Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids.
    Lövgren J; Valtonen-André C; Marsal K; Lilja H; Lundwall A
    J Androl; 1999; 20(3):348-55. PubMed ID: 10386814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of alpha-fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reaction.
    Ishikawa T; Kashiwagi H; Iwakami Y; Hirai M; Kawamura T; Aiyoshi Y; Yashiro T; Ami Y; Uchida K; Miwa M
    Jpn J Clin Oncol; 1998 Dec; 28(12):723-8. PubMed ID: 9879288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
    Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
    Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of human prostate-specific antigen gene expression in transgenic mice: evidence for an enhancer between the PSA and human glandular kallikrein-1 genes.
    Wei C; Callahan BP; Turner MJ; Willis RA; Lord EM; Barth RK; Frelinger JG
    Int J Mol Med; 1998 Oct; 2(4):487-96. PubMed ID: 9857240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the prostate specific antigen gene by lung tissue.
    Zarghami N; D'Costa M; Tsuyuki D; Asa SL; Diamandis EP
    Clin Cancer Res; 1997 Jul; 3(7):1201-6. PubMed ID: 9815800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time-resolved fluorescence imaging for specific and quantitative immunodetection of human kallikrein 2 and prostate-specific antigen in prostatic tissue sections.
    Siivola P; Pettersson K; Piironen T; Lövgren T; Lilja H; Bjartell A
    Urology; 2000 Oct; 56(4):682-8. PubMed ID: 11018639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue.
    Magklara A; Scorilas A; Stephan C; Kristiansen GO; Hauptmann S; Jung K; Diamandis EP
    Urology; 2000 Sep; 56(3):527-32. PubMed ID: 10962338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D.
    Hsieh ML; Charlesworth MC; Goodmanson M; Zhang S; Seay T; Klee GG; Tindall DJ; Young CY
    Cancer Res; 1997 Jul; 57(13):2651-6. PubMed ID: 9205072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors.
    Fisher TL; Nocera M; Willis RA; Turner MJ; Abdul Alim CS; Brown DM; Bourne PA; di Sant'Agnese PA; Messing EM; Lord EM; Frelinger JG
    Prostate; 2002 May; 51(3):153-65. PubMed ID: 11967950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate-specific human kallikrein (hK2) as a novel marker for prostate cancer.
    Young CY; Seay T; Hogen K; Charlesworth MC; Roche PC; Klee GG; Tindall DJ
    Prostate Suppl; 1996; 7():17-24. PubMed ID: 8950360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of recombinant PSA and HK2 and analysis of their immunologic cross-reactivity.
    Lövgren J; Piironen T; Overmo C; Dowell B; Karp M; Pettersson K; Lilja H; Lundwall A
    Biochem Biophys Res Commun; 1995 Aug; 213(3):888-95. PubMed ID: 7544581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling.
    Piironen T; Villoutreix BO; Becker C; Hollingsworth K; Vihinen M; Bridon D; Qiu X; Rapp J; Dowell B; Lövgren T; Pettersson K; Lilja H
    Protein Sci; 1998 Feb; 7(2):259-69. PubMed ID: 9521101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.
    Steuber T; Niemela P; Haese A; Pettersson K; Erbersdobler A; Felix Chun KH; Graefen M; Kattan MW; Huland H; Lilja H
    Prostate; 2005 Apr; 63(1):13-8. PubMed ID: 15378521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.
    Becker C; Piironen T; Pettersson K; Björk T; Wojno KJ; Oesterling JE; Lilja H
    J Urol; 2000 Jan; 163(1):311-6. PubMed ID: 10604382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative analysis of prostate-specific antigen gene sequence in benign and malignant prostate tissue.
    Baffa R; Moreno JG; Monne M; Veronese ML; Gomella LG
    Urology; 1996 Jun; 47(6):795-800. PubMed ID: 8677566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2.
    Lövgren J; Rajakoski K; Karp M; Lundwall â ; Lilja H
    Biochem Biophys Res Commun; 1997 Sep; 238(2):549-55. PubMed ID: 9299549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kallikrein gene expression in human pituitary tissues.
    Clements JA; Mukhtar A; Verity K; Pullar M; McNeill P; Cummins J; Fuller PJ
    Clin Endocrinol (Oxf); 1996 Feb; 44(2):223-31. PubMed ID: 8849579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production and activation of recombinant hK2 with propeptide mutations resulting in high expression levels.
    Lövgren J; Tian S; Lundwall A; Karp M; Lilja H
    Eur J Biochem; 1999 Dec; 266(3):1050-5. PubMed ID: 10583401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate-specific antigen and new related markers for prostate cancer.
    Daher R; Beaini M
    Clin Chem Lab Med; 1998 Sep; 36(9):671-81. PubMed ID: 9804390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.
    Haese A; Graefen M; Steuber T; Becker C; Noldus J; Erbersdobler A; Huland E; Huland H; Lilja H
    J Urol; 2003 Dec; 170(6 Pt 1):2269-73. PubMed ID: 14634394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.